Physician profile
Joseph M Moore
NPI 1104853142
$7,208.01
in general payments reported to CMS, 2019-2025
44 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,934 · 2020: $1,779 · 2021: $2,419 · 2022: $649 · 2024: $315 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,317.62 | 2019-2024 | Farxiga, Lokelma |
| Pfizer INC. | $617.78 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $576.77 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $489.42 | 2019-2022 | |
| Glaxosmithkline, LLC. | $453.59 | 2019-2022 | |
| Lilly USA, LLC | $345.40 | 2019-2021 | |
| Abbvie INC. | $334.12 | 2019-2022 | |
| Novo Nordisk INC | $302.50 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $295.14 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $146.63 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $145.14 | 2021 | |
| Merck Sharp & Dohme LLC | $140.87 | 2019-2022 | |
| Medicure Pharma INC. | $138.50 | 2020 | |
| Amarin Pharma, INC. | $137.41 | 2020-2022 | |
| Abiomed | $136.41 | 2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.